Seizure free days observed in randomised placebo-controlled trials with adjunctive levetiracetam in partial epilepsy

被引：0
|
作者：
Leppik, I
Morrell, M
Godfroid, P
Arrigo, C
机构：
[1] MINCE Epilepsy Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Minneapolis, MN 55455 USA
[3] Columbia Univ, Neurol Inst, New York, NY 10027 USA
[4] UCB Pharma, Outcomes Res, Braine lAlleud, Belgium
来源：
EPILEPSIA | 2003年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Onset of action of levetiracetam: A randomised, double-blind, placebo-controlled study with therapeutic intensive seizure analysis (TISA)
    Wan-Tilz, Y
    Stefan, H
    Pauli, E
    Genow, A
    Kerling, F
    Frauenberger, B
    Lorber, B
    Halboni, P
    Gefeller, O
    Tilz, C
    [J]. EPILEPSIA, 2005, 46 : 143 - 143
  • [22] Onset of action of levetiracetam: A randomised, double-blind, placebo-controlled study with therapeutic intensive seizure analysis (TISA)
    Wang-Tilz, Y
    Stefan, H
    Pauli, E
    Genow, J
    Kerling, F
    Frauenberger, B
    Lorber, B
    Halboni, P
    Gefeller, O
    Tilz, C
    [J]. EPILEPSIA, 2005, 46 : 192 - 192
  • [23] Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials
    Ma, Junpeng
    Huang, Siqing
    You, Chao
    [J]. EPILEPSY RESEARCH, 2015, 114 : 59 - 65
  • [24] CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS IN TWO INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Sperling, Michael R.
    Greenspan, A.
    Cramer, Joyce
    Kwan, Patrick
    Kalviainen, R.
    Halford, Jonathan J.
    Schmitt, Jennifer L.
    Haas, M.
    Yuen, Eric
    Novak, Gerad
    [J]. EPILEPSIA, 2008, 49 : 106 - 107
  • [25] Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial
    Keshavarzi, Amir
    Sharifi, Aziz
    Jahangard, Leila
    Soltanian, Alireza
    Bruehl, Annette Beatrix
    Ahmadpanah, Mohammad
    Brand, Serge
    [J]. NEUROPSYCHOBIOLOGY, 2022, 81 (03) : 192 - 203
  • [26] Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials
    Ryvlin, Philippe
    Cucherat, Michel
    Rheims, Sylvain
    [J]. LANCET NEUROLOGY, 2011, 10 (11): : 961 - 968
  • [27] GABAPENTIN AS ADD-ON THERAPY FOR REFRACTORY PARTIAL EPILEPSY - RESULTS OF 5 PLACEBO-CONTROLLED TRIALS
    LEIDERMAN, DB
    [J]. EPILEPSIA, 1994, 35 : S74 - S76
  • [28] Multicenter, double-blind, placebo-controlled trial of adjunctive levetiracetam (Keppra®) therapy (up to 60 mg/kg/day) in pediatric patients with refractory partial epilepsy
    Glauser, TA
    Gauer, LJ
    Chen, L
    [J]. EPILEPSIA, 2004, 45 : 186 - 186
  • [29] Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
    Savulescu, Julian
    Wartolowska, Karolina
    Carr, Andy
    [J]. JOURNAL OF MEDICAL ETHICS, 2016, 42 (12) : 776 - 783
  • [30] Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: A double-blind, randomized, placebo-controlled trial
    Peltola, Jukka
    Coetzee, Christo
    Jimenez, Fiacro
    Litovchenko, Tetyana
    Ramaratnam, Sridharan
    Zaslavaskiy, Leonid
    Lu, Zhihong
    Sykes, Deanne M.
    [J]. EPILEPSIA, 2009, 50 (03) : 406 - 414
12345